Skip to main content
SpringerLink
Log in

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

This overview tries to bridge the gap between psychoneuroimmunological findings and recent results from pharmacological, neurochemical and genetic studies in schizophrenia. Schizophrenia is a disorder of dopaminergic neurotransmission, but modulation of the dopaminergic system by glutamatergic neurotransmission seems to play a key role. This view is supported by genetic findings of the neuregulinand dysbindin genes, which have functional impact on the glutamatergic system. Glutamatergic hypofunction, however, is mediated by theN-methyl-D-aspartate (NMDA)-receptor antagonism. The only endogenous NMDA receptor antagonist identified up to now is kynurenic acid (KYNA). Despite the NMDA receptor antagonism, KYNA also blocks, in lower doses, the nicotinergic acetycholine receptor,i.e., increased KYNA levels can explain psychotic symptoms and cognitive deterioration. KYNA levels are described to be higher in the cerebrospinal fluid (CSF) and in critical central nervous system (CNS) regions of schizophrenics as compared to controls. Another line of evidence suggests that a (prenatal) infection is involved in the pathogenesis of schizophrenia. Due to an early sensitization process of the immune system or to a (chronic) infection, which is not cleared through the immune response, an immune imbalance between the type-1 and the type-2 immune responses takes place in schizophrenia. The type-1 response is partially inhibited, while the type-2 response is over-activated. This immune constellation is associated with inhibition of the enzyme indoleamine dioxygenase (IDO), because IDO — located in astrocytes and microglial cells — is inhibited by type-2 cytokines. IDO catalyzes the first step in tryptophan metabolism, the degradation from tryptophan to kynurenine, as does tryptophan 2,3-dioxygenase (TDO). Due to the inhibition of IDO, tryptophan-kynurenine is predominantly metabolized by TDO, which is located in astrocytes, not in microglial or other CNS cells. In schizophrenia, astrocytes in particular are activated, as increased levels of S100B appear. Additionally, they do not have the enzymatic equipment for the normal metabolism-route of tryptophan. Due to the lack of kynurenine hydroxylase (KYN-OHase) in astrocytes, KYNA accumulates in the CNS, while the metabolic pathway in microglial cells is blocked. Accordingly, an increase of TDO activity has been observed in critical CNS regions of schizophrenics. These mechanisms result in an accumulation of KYNA in critical CNS regions. Thus, the immune-mediated glutamatergic-dopaminergic dysregulation may lead to the clinical symptoms of schizophrenia. Therapeutic consequences,e.g., the use of antiinflammatory cyclo-oxygenase-2 inhibitors, which can also decrease KYNA directly, are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adler LE, A Olincy, M Waldo, JG Harris, J Griffith and K Stevens (1998) Schizophrenia, sensory gating, and nicotinic receptors.Schizophr. Bull. 24, 189–202.

    PubMed  CAS  Google Scholar 

  • Aloisi F, G Penna, J Cerase, B Menendez Iglesias and L Adorini (1997) IL-12 production by central nervous system microglia is inhibited by astrocytes.J. Immunol. 159, 1604–1612.

    PubMed  CAS  Google Scholar 

  • Aloisi F, F Ria and L Adorini (2000) Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes.Immunol. Today 21, 141–147.

    Article  PubMed  CAS  Google Scholar 

  • Andreasen NC, K Kezai, R Alliger, VW Swayze II, M Flaum, P Kirchneret al., (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia.Arch. Gen. Psychiatry 49, 943–958.

    PubMed  CAS  Google Scholar 

  • Ashdown H, Y Dumont, M Ng, S Poole, P Boksa and GN Luheshi (2006) The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia.Mol. Psychiatry 11, 47–55.

    Article  PubMed  CAS  Google Scholar 

  • Banks WA, AJ Kastin and EG Gutierrez (1993) Interleukin-1α has direct access to cortical brain cells.Neurosci. Lett. 163, 41–44.

    Article  PubMed  CAS  Google Scholar 

  • Bayer TA, R Buslei, L Havas and P Falkai (1999) Evidence for activation of microglia in patients with psychiatric illnesses.Neurosci. Lett. 27, 126–128.

    Article  Google Scholar 

  • Bechter K, V Schreiner, S Herzog, N Breitinger, KH Wollinsky, H Brinkmeier, P Aulkemeyer, F Weber and R Schuttler (2003) CSF filtration as experimental therapy in therapy-resistant psychoses in Borna disease virus-seropositive patients.Psychiatr. Prax. 30 (Suppl. 2), 216–220.

    PubMed  Google Scholar 

  • Bessler H, Z Levental, L Karp, I Modai, M Djaldetti and A Weizman (1995) Cytokine production in drug-free and neuroleptic-treated schizophrenic patients.Biol. Psychiatry 38, 297–302.

    Article  PubMed  CAS  Google Scholar 

  • Blackwell JM (2001) Genetics and genomics of infectious disease susceptibility.TIMM 7, 521–526.

    CAS  Google Scholar 

  • BleulerE (1911) Dementia praecox oder Gruppe der Schizophrenien, In:Handbuch der Psychiatrie (Aschaffenburg G, Ed.) (Deuticke: Leipzig, Wien).

    Google Scholar 

  • BoinF, R Zanardini, R Pioli, CA Altamura, M Maes and M Gennarelli (2001) Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia.Mol. Psychiatry 6, 79–82.

    Article  PubMed  CAS  Google Scholar 

  • Brown AS, MD Begg, S Gravenstein, CA Schaefer, RJ Wyatt, M Bresnahan, VP Babulas and ES Susser (2004) Serologic evidence of prenatal influenza in the etiology of schizophrenia.Arch. Gen. Psychiatry 61, 774–780.

    Article  PubMed  Google Scholar 

  • Buka SL, MT Tsuang, EF Torrey, MA Klebanoff, D Berstein and RH Yolken (2001) Maternal infections and subsequent psychosis in the offspring.Arch. Gen. Psychiatry 58, 1032–1037.

    Article  PubMed  CAS  Google Scholar 

  • Buonanno A and GD Fischbach (2001) Neuregulin and ErbB receptor signaling pathways in the nervous system.Curr. Opin. Neurobiol. 11(3), 287–296.

    Article  PubMed  CAS  Google Scholar 

  • Cannon M, D Cotter, VP Coffey, PC Sham, N Takei, C Larkin, RM Murray and E O’Callaghan (1996) Prenatal exposure to the 1957 influenza epidemic and adult schizophrenia: a follow-up study.Br. J. Psychiatry 168, 368–371.

    Article  PubMed  CAS  Google Scholar 

  • Cannon TD, TG van Erp, IM Rosso, M Huttunen, J Lonnqvist, T Pirkola, O Salonen, L Valanne, VP Poutanen and CG Standertskjold-Nordenstam (2002) Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls.Arch. Gen. Psychiatry 59(1), 35–41.

    Article  PubMed  Google Scholar 

  • Cardno AG, EJ Marshall, B Coid, AM Macdonald, TR Ribchester, NJ Davies, P Venturi, LA Jones, SW Lewis, PC Sham, II Gottesman, AE Farmer, P McGuffin, AM Reveley and RM Murray (1999) Heritability estimates for psychotic disorders: the Maudsley twin psychosis series.Arch. Gen. Psychiatry 56, 162–168.

    Article  PubMed  CAS  Google Scholar 

  • Carlin JM, EC Borden, PM Sondel and GI Byrne (1989) Interferon-induced indoleamine 2,3-dioxygenase activity in human mono-nuclear phagocytes.J. Leukoc. Biol. 45, 29–34.

    PubMed  CAS  Google Scholar 

  • Carlsson A (1978) Antipsychotic drugs, neurotransmitters, and schizophrenia.Am. J. Psychiatry 135, 165–173.

    PubMed  CAS  Google Scholar 

  • Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia.Neuropsychopharmacol. 1, 179–186.

    Article  CAS  Google Scholar 

  • Carlsson A (1998) Schizophrenie und Neurotransmitterstöru ngen. Neue Perspektiven und therapeutischen Ansätze, In:Schizophrenie — Moderne Konzepte zu Diagnostik, Pathogenese und Therapie (Möller H-J and N Müller, Eds.) (Springer Verlag: Wien, NY),pp 93–116.

    Google Scholar 

  • Carlsson A, N Waters, S Holm-Waters, J Tedroff Jr, M Nilsson and ML Carlsson (2001) Interactions between monoamines, glutamate and GABA in schizophrenia: new evidence.Annu. Rev. Pharmacol. Toxicol. 41, 237–260.

    Article  PubMed  CAS  Google Scholar 

  • Casolini P, A Catalani, AR Zuena and L Angelucci (2002) Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioural impairments in the rat.J. Neurosci. Res. 68, 337–343.

    Article  PubMed  CAS  Google Scholar 

  • Cazzullo CL, S Scarone, B Grassi, C Vismara, D Trabattoni and M Clerici (1998) Cytokines production in chronic schizophrenia patients with or without paranoid behavior.Prog. Neuro-Psychopharmacol. Biol. Psychiatry 22, 947–957.

    Article  CAS  Google Scholar 

  • Ceresoli-Borroni G, HQ Wu, P Guidetti, A Rassoulpour, AC Roberts and R Schwarcz (1999) Chronic haloperidole administration decreases kynurenic acid levels in rat brain.Soc. Neurosci. Abstr. 25, 7278.

    Google Scholar 

  • Ceresoli-Borroni G, A Rassoulpour, HQ Wu, P Guidetti and R Schwarcz (2006) Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.J. Neural Transm. E-pub, February 9.

  • Chiarugi A, R Carpenedo and F Moroni (1996) Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and kynureninase.J. Neurochem. 67, 692–698.

    PubMed  CAS  Google Scholar 

  • Clunie M, LA Crone, L Klassen and R Yip (2003) Psychiatric side effects of indomethacin in parturients.Can. J. Anaesth. 50, 586–588.

    PubMed  Google Scholar 

  • Collier DA and T Li (2003) The genetics of schizophrenia: glutamate not dopamine.Eur. J. Pharmacol. 480, 177–184.

    Article  PubMed  CAS  Google Scholar 

  • Cook GS and AV Hill (2001) Genetics of susceptibility to human infectious disease.Nat. Rev. Genetics 2, 967–977.

    Article  CAS  Google Scholar 

  • Cornblatt BI, M Obuchowski, S Roberts, S Pollack and E Erlenmeyer-Kimling (1999) Cognitive and behavioural precursors of schizophrenia.Dev. Psychopathol. 11, 487–508.

    Article  PubMed  CAS  Google Scholar 

  • Das I and NS Khan (1998) Increased arachidonic acid induced platelet chemoluminiscence indicates cyclooxygenase overactivity in schizophrenic subjects.Prostaglandins, Leukot. Essent. Fatty Acids 58, 165–168.

    Article  CAS  Google Scholar 

  • Dean K and RM Murray (2005) Environmental risk factors for psychosis.Dialogues Clin. Neurosci. 7, 69–80.

    PubMed  Google Scholar 

  • DeLisi LE, S Goodman, LM Neckers and RJ Wyatt (1982) An analysis of lymphocyte subpopulations in schizophrenic patients.Biol. Psychiatry 17, 1003–1009.

    PubMed  CAS  Google Scholar 

  • Erhardt S and G Engberg (2002) Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.Acta Physiol. Scand. 175(1), 45–53.

    Article  PubMed  CAS  Google Scholar 

  • Erhardt S K Blennow, C Nordin, E Skogh, LH Lindstrom and G Engberg (2001a) Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.Neurosci. Lett. 313, 96–98.

    Article  PubMed  CAS  Google Scholar 

  • Erhardt S, H Oberg, JM Mathe and G Engberg (2001b) Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons.Amino Acids 20(4), 353–362.

    Article  PubMed  CAS  Google Scholar 

  • Erhardt S, L Schwieler and G Engberg (2003) Kynurenic acid and schizophrenia.Adv. Exp. Med. Biol. 527, 155–165.

    PubMed  CAS  Google Scholar 

  • Espey MG, ON Chernyshev, JJ Reinhard, MA Namboodiri and CA Colton (1997) Activated human microglia produce the excitotoxin quinolinic acid.Neuroreport 8, 431–434.

    Article  PubMed  CAS  Google Scholar 

  • Farber NB, DF Wozniak, MT Price, J Labruyere, J Huss, H St Peter and JW Olney (1995) Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?Biol. Psychiatry 38(12), 788–796.

    Article  PubMed  CAS  Google Scholar 

  • Fearon P, P Cotter and RM Murray (2000) Is the association between obstretic complications and schizophrenia mediated by glutaminergic excitotoxic damage of the foetal/neonatal brain? In:Psychopharmacology of Schizophrenia (Revely M and B Deacon, Eds.) (Chapman and Hall:London), pp 21–40.

    Google Scholar 

  • Fortier M-E, R Joober, GN Luheshi and P Boksa (2004) Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring.J. Psychiatr. Res. 38, 335–345.

    Article  PubMed  Google Scholar 

  • Frommberger UH, J Bauer, P Haselbauer, A Fraulin, D Riemann and M Berger (1997) Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.Eur. Arch. Psychiatry Clin. Neurosci. 247, 228–233.

    Article  PubMed  CAS  Google Scholar 

  • Furukawa H, A del Rey, G Monge-Arditi and HO Besedovsky (1998) Interleukin-1, but not stress, stimulates glucocorticoid output during early postnatal life in mice. Ann.NY Acad. Sci. 840, 117–122.

    Article  CAS  Google Scholar 

  • Gal EM (1974) Cerebral tryptophan-2,3-dioxygenase (pyrrolase) and its induction in rat brain.J. Neurochem. 22, 861–863.

    Article  PubMed  CAS  Google Scholar 

  • Ganguli R, BS Rabin, RH Kelly, M Lyte and U Ragu (1987) Clinical and laboratory evidence of autoimmunity in acute schizophrenia.Ann. NY Acad. Sci. 496, 676–685.

    Article  PubMed  CAS  Google Scholar 

  • Ganguli R, Z Yang, G Shurin, R Chengappa, JS Brar, AV Gubbi and BS Rabin (1994) Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness.Psychiatry Res. 51, 1–10.

    Article  PubMed  CAS  Google Scholar 

  • Ganguli R, JS Brar, KR Chengappa, M DeLeo, ZW Yang, G Shurin and B Rabin (1995) Mitogen-stimulated interleukin 2 production in never-medicated, first episode schizophrenics — the influence of age of onset and negative symptoms.Arch. Gen. Psychiatry 52, 668–672.

    PubMed  CAS  Google Scholar 

  • Gattaz WF, AL Abrahao and R Foccacia (2004) Childhood meningitis, brain maturation and the risk of psychosis.Eur. Arch. Psychiatry Clin. Neurosci. 254, 9–13.

    Article  Google Scholar 

  • Gholson RK, LV Hankes and LM Henderson (1960) 3- Hydroxyanthranilic acid as an intermediate in the oxidation of the indole nucleus of tryptophan.J. Biol. Chem. 235, 132–135.

    PubMed  CAS  Google Scholar 

  • Green MF and KH Nuechterlein (1999) Should schizophrenia be treated as a neurocognitive disorder?Schizophr. Bull. 25, 309–319.

    PubMed  CAS  Google Scholar 

  • Grishin AA, P Bequet and U Gerber (2005) Muscarinic receptor stimulation reduces NMDA responses in CA3 hippocampal pyramidal cells via Ca2+-dependent activation of tyrosine phosphatase.Neuropharmacology 49, 328–337.

    Article  PubMed  CAS  Google Scholar 

  • Grohmann U, F Fallarino and P Puccetti (2003) Tolerance, DCs and tryptophan: much ado about IDO.Trends Immunol. 24, 242–248.

    Article  PubMed  CAS  Google Scholar 

  • Grosskopf A, N Müller, A Malo and R Wank (1998) Potential role for the narcolepsy- and multiple sclerosis-associated allele DQB1*0602 in schizophrenia subtypes.Schizophr. Res. 30, 187–189.

    Article  PubMed  CAS  Google Scholar 

  • Grotta J (1994) Safety and tolerability of the glutamate receptor antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke.Stroke 26, 602–605.

    Google Scholar 

  • Guillemin GJ, SJ Kerr, GA Smythe, DG Smith, V Kapoor, PJ Armati, J Croitoru and BJ Brew (2003) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.J. Neural Transm. 110, 1–14.

    Google Scholar 

  • Haack M, D Hinze-Selch, T Fenzel, T Kraus, M Kuhn, A Schuld and T Pollmacher (1999) Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.J. Psychiatr. Res. 33, 407–418.

    Article  PubMed  CAS  Google Scholar 

  • Haber R, D Bessette, B Hulihan-Giblin, MJ Durcan and D Goldman (1993) Identification of tryptophan-2,3-dioxygenase RNA in rodent brain.J. Neurochem. 60, 1159–1162.

    Article  PubMed  CAS  Google Scholar 

  • Harris SG, J Padilla, L Koumas, D Ray and RP Phipps (2002) Prostaglandins as modulators of immunity.Trends Immunol. 23, 144–150.

    Article  PubMed  CAS  Google Scholar 

  • Harrison PJ and DR Weinberger (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.Mol. Psychiatry 10, 40–68.

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto PH (1991) Aspects of normal cerebrospinal fluid circulation and circumventricular organs.Prog. Brain Res. 91, 439–443.

    Article  Google Scholar 

  • Heresco-Levy U (2003) Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 1113–1123.

    Article  PubMed  CAS  Google Scholar 

  • Heresco-Levy U, DC Javitt, M Ermilov, C Mordel, G Silipo and M Lichtenstein (1999) Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.Arch. Gen. Psychiatry 56, 29–36.

    Article  PubMed  CAS  Google Scholar 

  • Herrling PL (1994) D-CPPene (SDZ EAA 494), a competitive NMDA receptor antagonist: results from animal models and first results in humans.Neuropsychopharmacol. 10 (3S) 591S.

    Google Scholar 

  • Heyes MP, CL Achim, CA Wiley, EO Major, K Saito and SP Markey (1996) Human microglia convert L-tryptophan into the neurotoxin quinolinic acid.Biochem. J. 320, 595–597.

    PubMed  CAS  Google Scholar 

  • Heyes MP, CY Chen, EO Major and K Saito (1997a) Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.Biochem. J. 326, 351–356.

    PubMed  CAS  Google Scholar 

  • Heyes MP, K Saito, CY Chen, MG Proescholdt, TS Nowak, J Li, KE Beagles, MA Proescholdt, MA Zito, K Kawai and SP Markey (1997b) Species heterogeneity between gerbils and rats: quino-linate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation.J. Neurochem. 69, 1519–1529.

    Article  PubMed  CAS  Google Scholar 

  • Hilkens CM, A Snijders, FG Snijdewint, EA Wierenga and ML Kapsenberg (1996) Modulation of T-cell cytokine secretion by accessory cell-derived products.Eur. Respir. J. Suppl.22, 90s-94s.

    CAS  Google Scholar 

  • Hill AV (1999) Genetics of infectious disease resistance.Curr. Opin. Genet. Dev. 6, 348–353.

    Article  Google Scholar 

  • Hilmas C, EF Pereira, M Alkondon, A Rassoulpour, R Schwarcz and EX Albuquerque (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.J. Neurosci. 21, 7463–7473.

    PubMed  CAS  Google Scholar 

  • Hinson RM, JA Williams and E Shacter (1996) Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.Proc. Natl. Acad. Sci. USA 93, 4885–4890.

    Article  PubMed  CAS  Google Scholar 

  • Hornberg M, V Arolt, I Wilke, A Kruse and H Kirchner (1995) Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia.Schizophr. Res. 15, 237–242.

    Article  PubMed  CAS  Google Scholar 

  • Huber G (1983) Das Konzept substratnaher Basissymptome und seine Bedeutung für Theorie und Therapie schizophrener Erkrankungen.Nervenarzt. 54, 23–32.

    PubMed  CAS  Google Scholar 

  • Hyde TM and JM Crook (2001) Cholinergic systems and schizophrenia: primary pathology or epiphenomena?J. Chem. Neuroanat. 22, 53–63.

    Article  PubMed  CAS  Google Scholar 

  • Jablensky A (2000) Epidemiology of schizophrenia: the global burden of disease and disability.Eur. Arch. Psychiatry Clin. Neurosci. 250, 274–285.

    Article  PubMed  CAS  Google Scholar 

  • Jentsch JD and RH Roth (1999) The neuropharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.Neuropsychopharmacology 20, 201–224.

    Article  PubMed  CAS  Google Scholar 

  • KabierschA, H Furukawa, A del Rey and HO Besedovsky (1998) Administration of interleukin-1 at birth affects dopaminergic neurons in adult mice. Ann.NY Acad. Sci. 840, 123–127.

    Article  CAS  Google Scholar 

  • Kaiya H, M Uematsu, M Ofuji, A Nishida, K Takeuchi, M Nozaki and E Idaka (1989) Elevated plasma prostaglandin E2 levels in schizophrenia.J. Neural Transm. 77, 39–46.

    Article  PubMed  CAS  Google Scholar 

  • Kallmann FJ and D Reisner (1943) Twin studies on the genetic variation in resistance to tuberculosis.J. Heredity 34.

  • Kilidireas K, N Latov, DH Strauss, DG Aviva, GA Hashim, JM Gorman and SA Sadiq (1992) Antibodies to human 60 KD hear-shock protein in patients with schizophrenia.Lancet 340, 569–572.

    Article  PubMed  CAS  Google Scholar 

  • Kim JS, HH Kornhuber, W Schmid-Burgk and B Holzmuller (1980) Low cerebrospinal fluid glutamate in schizophrenia patients and a new hypothesis of glutamatergic neuronal dysfunction.Neurosci. Lett. 20, 379–382.

    Article  PubMed  CAS  Google Scholar 

  • Kiss C, G Ceresoli-Borroni, P Guidetti, CL Zielke, HR Zielke and R Schwarcz (2003) Kynurenate production by cultured human astrocytes.J. Neural Transm. 110, 1–14.

    PubMed  CAS  Google Scholar 

  • Koponen H, P Rantakallio, J Veijola, P Jones, J Jokelainen and M Isohanni (2004) Childhood central nervous system infections and risk for schizophrenia.Eur. Arch. Psychiatry Clin. Neurosci. 254, 9–13.

    Article  PubMed  Google Scholar 

  • Kornhuber J, J Wiltfang and S Bleich (2004) The etiopathogenesis of schizophrenia.Pharmacopsychiatr. 37 Suppl. 2, S103-S112.

    Article  CAS  Google Scholar 

  • Körschenhausen D, H Hampel, M Ackenheil, R Penning and N Müller (1996) Fibrin degradation products in post mortem brain tissue of schizophrenics: a possible marker for underlying inflammatory processes.Schizophr. Res. 19, 103–109.

    Article  PubMed  Google Scholar 

  • Kotake Y and T Masayama (1937) Über den Mechanismus der Kynurein-Bildung aus Tryptophan.Hoppe-Seyler’s Z. Physiol. Chem. 243, 237–244.

    Google Scholar 

  • Kraepelin E(1899) Psychiatrie.Ein Lehrbuch für Studierende und Ärzte, Vol. 6 (Barth:Leipzig).

    Google Scholar 

  • Kristensen JD, B Svensson and T Gordh (1992) The NMDA receptor antagonist CPP abolishes neurogenig ‘wind-up’ after intrathecal administration in humans.Pain 51, 249–253.

    Article  PubMed  CAS  Google Scholar 

  • Krönig H, M Riedel, MJ Schwarz, M Strassnig, HJ Möller, M Ackenheil and N Müller (2005) ICAM G241A polymorphism and soluble ICAM-1 serum levels — evidence for an active immune process in schizophrenia.Neuroimmunomodulation 12, 54–59.

    Article  PubMed  CAS  Google Scholar 

  • Krystal JH, LP Karper, JP Seibyl, R Delaney, JD Bremner, MB Bowers Jr, DS Charney (1993) Dose related effects of the NMDA antagonist, ketamine, in healthy humans.Schizophr. Res. 9, 240–241.

    Article  Google Scholar 

  • Krystal JH, LP Karper, JP Seibyl, GK Freeman, R Delaney, JD Bremner, GR Heninger, MB Bowers Jr and DS Charney (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.Arch. Gen. Psychiatry 51(3), 199–214.

    PubMed  CAS  Google Scholar 

  • Kuhlman P, VT Moy, BA Lollo and AA Brian (1991) The accessory function of murine intercellular adhesion molecule-1 in T-lymphocyte activation: contribution of adhesion and co-activation. J.Immunol. 146, 1773–1782.

    CAS  Google Scholar 

  • Laruelle M, A Abi-Dargham, CH van Dyck, R Gil, CD D’Souza, J Erdos, E McCance, W Rosenblatt, C Fingado, SS Zoghbi, RM Baldwin, JP Seibyl, JH Krystal, DS Charney and RB Innis (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.Proc. Natl. Acad. Sci. USA 93, 9235–9240.

    Article  PubMed  CAS  Google Scholar 

  • Laumbacher B, N Müller, B Bondy, B Schlesinger, S Gu, B Fellerhoff and R Wank (2003) Significant frequency deviation of the class I polymorphism HLA-A10 in schizophrenic patients.J. Med. Genet. 40, 217–219.

    Article  PubMed  CAS  Google Scholar 

  • Leiderman E, I Zylberman, SR Zukin, TB Cooper and DC Javitt (1996) Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.Biol. Psychiatry 39, 213–215.

    Article  PubMed  CAS  Google Scholar 

  • Leweke FM, CW Gerth, D Koethe, J Klosterkotter, I Ruslanova, B Krivogorsky, EF Torrey and RH Yolken (2004) Antibodies to infectious agents in individuals with recent onset schizophrenia.Eur. Arch. Psychiatry Clin. Neurosci. 254, 4–8.

    Article  PubMed  Google Scholar 

  • Lin A, G Kenis, S Bignotti, GJB Tura, R De Jong, E Bosmans, R Pioli, C Altamura, S Scharpé and M Maes (1998) The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.Schizophr. Res. 32, 9–15.

    Article  PubMed  CAS  Google Scholar 

  • Litherland SA, XT Xie, AD Hutson, C Wasserfall, DS Whittaker, JX She, A Hofig, MA Dennis, K Fuller, R Cook, D Schztz, LL Moldawer and MJ Clare-Salzier (1999) Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus.J. Clin. Invest. 104, 515–523.

    Article  PubMed  CAS  Google Scholar 

  • Lodge D, JA Aram, J Church, SN Davies, D Martin, CT ’Shoughnessy, ZS Zeman (1987) Excitatory amino acids and phencyclidine-like drugs, In:Excitatory Amino Acid Transmission (Hicks TP, D Lodge and H McLennan, Eds.), (Alan R Liss Inc: New York, NY), pp 83–90.

    Google Scholar 

  • Lohr JB and K Flynn (1992) Smoking and schizophrenia.Schizophr. Res. 8, 93–102.

    Article  PubMed  CAS  Google Scholar 

  • Mach DM, C Schütt and I Börner (1983) Schizophrenie und B- Lymphozytenalteration — eine Hypothese.Psychiatrie, Neurologie und Medizinische Psychologie 35, 390–397.

    CAS  Google Scholar 

  • Maes M, E Bosmans, J Calabrese, R Smith and HY Meltzer (1995) Interleukin-2 and Interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood-stabilizers.J. Psychiatr. Res. 29, 141–152.

    Article  Google Scholar 

  • Maes M, E Bosmans, G Kenis, R De Jong, RS Smith and HY Meltzer (1997)In vivo immunomodulatory effects of clozapine in schizophrenia.Schizophr. Res. 26, 221–225.

    Article  PubMed  CAS  Google Scholar 

  • Maino K, R Gruber, M Riedel, N Seitz, MJ Schwarz and N Müller (2006) T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment.Psychiatry Res. (in press).

  • Marshall BE and DE Longnecker (1990) General anesthetics, In:The Pharmacological Basis of Therapeutics (Goodman LS, A Gilman, TW Rall, AS Nies P Taylor, Eds.) (Pergamon Press: Elmsford NY), pp 285–310.

    Google Scholar 

  • Marshall B, DB Keskin and AL Mellor (2001) Regulation of prostaglandin synthesis and cell adhesion by a tryptophan catabolizing enzyme.BMC Biochemistry 2, 5.

    Article  PubMed  CAS  Google Scholar 

  • Martin LF, WR Kem and R Freedman (2004) Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.Psychopharmacol. (Berl.) 174, 54–64.

    Article  CAS  Google Scholar 

  • Mattsson A, E Lindqvist, SO Ogran and L Olson (2005) Increased phencyclidine-induced hyperactivity following cortical cholinergic denervation.Neuroreport. 16(16), 1815–1819.

    Article  PubMed  CAS  Google Scholar 

  • McAllister CG, MH Rapaport, D Pickar and SM Paul (1989) Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients.Arch. Gen. Psychiatry 46, 956–957.

    PubMed  CAS  Google Scholar 

  • McNeil TF, E Cantor-Graae and DR Weinberger (2000) Relationship of abstretic complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia.Am. J. Psychiatry 157, 203–212.

    Article  PubMed  CAS  Google Scholar 

  • Mednick SA, RA Machon, MO Huttunen and D Bonett (1988) Adult schizophrenia following prenatal exposure to an influenza epidemic.Arch. Gen. Psychiatry 45, 817–824.

    Google Scholar 

  • Meira-Lima IV, AC Pereira, GF Mota, M Floriano, F Araujo, AJ Mansur, JE Krieger and H Vallada (2003) Analysis of a polymorphism in the promoter region of the tumor necrosis factor-α gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia.Mol. Psychiatry 8, 718–720.

    Article  PubMed  CAS  Google Scholar 

  • Miller CL, IC Llenos, JR Dulay, MM Barillo, RH Yolken and S Weis (2004) Expression of the kynurenine pathway enzyme tryptophane 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia.Neurobiol. Dis. 15, 618–629.

    Article  PubMed  CAS  Google Scholar 

  • Miller DW and ED Abercrombie (1996) Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured within vivo microdialysis in awake rats.Brain Res. Bull. 40, 57–62.

    Article  PubMed  CAS  Google Scholar 

  • Miller R and G Chouinard (1993) Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia.Biol. Psychiatry 34, 713–38.

    Article  PubMed  CAS  Google Scholar 

  • Mills CD, K Kincaid, JM Alt, MJ Heilman and AM Hill (2000) Macrophages and the Th1/Th2 paradigm.J. Immunol. 164, 6166–6173.

    PubMed  CAS  Google Scholar 

  • Mittleman BB, FX Castellanos, LK Jacobson, JL Rapoport, SE Swedo and GM Shearer (1997) Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease.J. Immunol. 159, 2994–2999.

    PubMed  CAS  Google Scholar 

  • Molholm HB (1942) Hyposensitivity to foreign protein in schizophrenic patients.Psychiatr. Quart. 16, 565–571.

    Google Scholar 

  • Moller HJ (2003) Management of the negative symptoms of schizophrenia: new treatment options.CNS Drugs 17, 793–823.

    Article  PubMed  Google Scholar 

  • Müller N(2004) Immunological and infectious aspects of schizophrenia (Editorial).Eur. Arch. Psychiatry Clin. Neurosci. 254, 1–3.

    Article  PubMed  Google Scholar 

  • Müller N and M Ackenheil (1995) Immunoglobulin and albumin contents of cerebrospinal fluid in schizophrenic patients: the relationship to negative symptomatology.Schizophr. Res. 14, 223–228.

    Article  PubMed  Google Scholar 

  • Müller N and M Ackenheil (1998) Psychoneuroimmunology, the cytokine network in the CNS, and the implications for psychiatric disorders.Progr. Neuro-Psychopharmacol. Biol. Psychiatry 22, 1–31.

    Article  Google Scholar 

  • Müller N, M Ackenheil, E Hofschuster, W Mempel and R Eckstein (1991) Cellular immunity in schizophrenic patients before and during neuroleptic therapy.Psychiatry Res. 37, 147–160.

    Article  PubMed  Google Scholar 

  • Müller N, M Empel, M Riedel, MJ Schwarz and M Ackenheil (1997a) Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia.Eur. Arch. Psychiatry Clin. Neurosci. 247, 308–313.

    Article  PubMed  Google Scholar 

  • Müller N, P Dobmeier, M Empel, M Riedel, M Schwarz and M Ackenheil (1997b) Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients.Eur. Psychiatry 12, 294–299.

    Article  PubMed  Google Scholar 

  • Müller N, M Riedel, M Schwarz, R Gruber and M Ackenheil (1997c) Immunomodulatory effects of neuroleptics to the cytokine system and the cellular immune system in schizophrenia, In:Current Update in Psychoimmunology (Wieselmann G, Ed.) (Springer Verlag:Wien, NY), pp 57–67.

    Google Scholar 

  • Müller N, BC Schlesinger, M Hadjamu, M Riedel, MJ Schwarz, J Primbs, M Ackenheil, R Wank and R Gruber (1998) Cytotoxic gamma/delta cells (g/d+CD8+) are elevated in unmedicated schizophrenic patients and related to the blood-brain barrier and the HLA allele DPA 02011.Schizophr. Res. 12, 69–71.

    Article  Google Scholar 

  • Müller N, M Hadjamu, M Riedel, J Primbs, M Ackenheil and R Gruber (1999) The adhesion-molecule receptor expression on T helper cells increases during treatment with neuroleptics and is related to the blood-brain barrier permeability in schizophrenia.Am. J. Psychiatry 156, 634–636.

    PubMed  Google Scholar 

  • Müller N, M Riedel, M Ackenheil and MJ Schwarz (2000) Cellular and humoral immune system in schizophrenia: a conceptual reevaluation.World J. Biol. Psychiatry 1, 173–179.

    Article  PubMed  Google Scholar 

  • Müller N, M Riedel, C Scheppach, B Brandstätter, S Sokkullu, K Krampe, M Ulmschneider, H-J Möller and M Schwarz (2002) Beneficial anti-psychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.Am. J. Psychiatry 159, 1029–1034.

    Article  PubMed  Google Scholar 

  • Müller N, M Ulmschneider, C Scheppach, MJ Schwarz, M Ackenheil, H-J Möller, R Gruber and M Riedel (2004a) COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy.Eur. Arch. Psychiatry Clin. Neurosci. 254, 14–22.

    Article  PubMed  Google Scholar 

  • Müller N, M Riedel and MJ Schwarz (2004b) Psychotropic effects of COX-2 inhibitors — a possible new approach for the treatment of psychiatric disorders.Pharmacopsychiatr. 37, 266–269.

    Article  CAS  Google Scholar 

  • Müller N, M Riedel, MJ Schwarz and RR Engel (2005) Clinical effects of COX-2 inhibitors on cognition in schizophrenia.Eur. Arch. Psychiatry Clin. Neurosci. 255, 149–151.

    Article  PubMed  Google Scholar 

  • Murray RM and SW Lewis (1987) Is schizophrenia a neurodevel-opmental disorder?BMJ 295, 681–682.

    Article  PubMed  CAS  Google Scholar 

  • Neidhart M, F Pataki and K Fehr (1995) Increased soluble endothelial adhesion molecules in rheumatoid arthritis correlate with circulating cytokines and depletion of CD45R0+ T-lymphocytes from blood stream.Schweiz. Med. Wochenschr. 125, 424–428.

    PubMed  CAS  Google Scholar 

  • Nilsson LK, L Schwieler, G Engberg, KR Linderholm and S Erhardt (2005) Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms.Int. J. Neuropsychopharmacol. 8(3):329–339. E-pub Feb 18.

    Article  PubMed  CAS  Google Scholar 

  • Nishino S, E Mignot, KL Benon and VP Zarcone Jr (1998) Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture.Psychiatry Res. 78, 141–150.

    Article  PubMed  CAS  Google Scholar 

  • Numakawa T, Y Yagasaki, T Ishimoto, T Okada, T Suzuki, N Iwata, N Ozaki, T Taguchi, M Tatsumi, K Kamijima, RE Straub, DR Weinberger, H Kunugi and R Hashimoto (2004) Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.Hum. Mol. Genet. 13, 2699–2708.

    Article  PubMed  CAS  Google Scholar 

  • Olney JW and NB Farber (1995) Glutamate receptor dysfunction and schizophrenia.Arch. Gen. Psychiatry 52, 998–1007.

    PubMed  CAS  Google Scholar 

  • Ozawa K, K Hashimoto, T Kishimoto, E Shimizu, H Ishikura and M Iyo (2006) Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.Biol. Psychiatry 59(6), 546–554. E-pub 2005 Oct 26.

    Article  PubMed  CAS  Google Scholar 

  • Özek M, K Toreci, I Akkok and Z Genever (1971) [Influence of therapy on antibody-formation].Psychopharmacologia 21, 401–412.

    Article  PubMed  Google Scholar 

  • Paludan SR (1998) Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship.Scand. J. Immunol. 48, 459–468.

    Article  PubMed  CAS  Google Scholar 

  • Parsons CG, W Danysz, G Quack, S Hartmann, B Lorenz, C Wollenburg, L Baran, E Przegalinski, W Kostowski, P Krzascik, B Chizh and PM Headley (1997). Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.J. Pharmacol. Exp. Ther. 283, 1264–1275.

    PubMed  CAS  Google Scholar 

  • Pearce BD (2001) Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms.Mol. Psychiatry 6, 634–646.

    Article  PubMed  CAS  Google Scholar 

  • Picciotto MR, BJ Caldarone, SL King and V Zachariou (2000) Nicotinic receptors in the brain. Links between molecular biology and behavior.Neuropsychopharmacology 22, 451–465.

    Article  PubMed  CAS  Google Scholar 

  • Pollmächer T, D Hinze-Selch and J Mullington (1996) Effects of clozapine on plasma cytokine and soluble cytokine receptor levels.J. Clin. Pharmacol. 16, 403–409.

    Google Scholar 

  • Pyeon D, FJ Diaz and GA Splitter (2000) Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.J. Virol. 74, 5740–5745.

    Article  PubMed  CAS  Google Scholar 

  • Ramchand R, J Wei, CN Ramchand and GP Hemmings (1994) Increased serum IgE in schizophrenic patients who responded poorly to neuroleptic treatment.Life Sci. 54, 1579–1584.

    Article  PubMed  CAS  Google Scholar 

  • Rantakallio P, P Jones, J Moring and L von Wendt (1997) Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up.Int. J. Epidemiol. 26, 837–843.

    Article  PubMed  CAS  Google Scholar 

  • Rapaport MH and N Müller (2001) Immunological states associated with schizophrenia, In:Psychoneuroimmunolgy, 3rd Edition, Vol. 2 (Chapter 48) (Ader A, DL Felten and N Cohen, Eds.) (Academic Press:San Diego, NY), pp 373–382.

    Google Scholar 

  • Riedel M. H Krönig, MJ Schwarz, RR Engel, KU Kühn, CH Sikorski, S Sokullu, M Ackenheil, HJ Möller and N Müller (2002) No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia.Eur. Arch. Psychiatry Clin. Psychiatr. 252, 232–234.

    Article  Google Scholar 

  • Riedel M, M Strassnig, I Spellmann, CH Sikorski, MJ Schwarz, HJ Möller and N Müller (2006) Decreased T cellular immune response in schizophrenic patients.J. Psychiatr. Res. Jan. 21, E-pub ahead of print.

  • Romagnani S (1995) Biology of human TH1 and TH2 cells.J. Clin. Immunol. 15, 121–129.

    Article  PubMed  CAS  Google Scholar 

  • Rothermundt M, V Arolt, C Weitzsch, D Eckhoff and H Kirchner (1996) Production of cytokines in acute schizophrenic psychosis.Biol Psychiatry 40(12), 1294–1297.

    Article  PubMed  CAS  Google Scholar 

  • Rothermundt M, G Ponath and V Arolt (2004a) S100B in schizophrenic psychosis.Int. Rev. Neurobiology 59, 445–470.

    Article  CAS  Google Scholar 

  • Rothermundt M, P Falkai, G Ponath, S Abel, H Bürkle, M Diedrich, G Hetzel, M Peters, A Siegmund, A Pedersen, W Maier, J Schramm, T Suslow, P Ohrmann and V Arolt (2004b) Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF.Mol. Psychiatry 9, 897–899.

    Article  PubMed  CAS  Google Scholar 

  • Rothermundt M, G Ponath, T Glaser, G Hetzel and V Arolt (2004c) S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia.Neuropsychopharmacol. 29, 1004–1011.

    Article  CAS  Google Scholar 

  • Sarter M, CL Nelson and JP Bruno (2005) Cortical cholinergic transmission and cortical information processing in schizophrenia.Schizophr. Bull. 31, 117–138.

    Article  PubMed  Google Scholar 

  • Schwab SG, M Albus, J Hallmayer, S Honig, M Borrmann, D Lichtermann, RP Ebstein, M Ackenheil, B Lerer and N Risch (1995) Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis.Nat. Genet. 11(3), 325–327.

    Article  PubMed  CAS  Google Scholar 

  • Schwab SG, J Hallmayer, M Albus, B Lerer, GN Eckstein, M Borrmann, RH Segman, C Hanses, J Freymann, A Yakir, M Trixler, P Falkai, M Rietschel, W Maier and DB Wildenauer (2000) A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6.Mol. Psychiatry 5, 638–649.

    Article  PubMed  CAS  Google Scholar 

  • Schwab SG, M Knapp, S Mondabon, J Hallmayer, M Borrmann-Hassenbach, M Albus, B Lerer, M Rietschel, M Trixler, W Maier and DB Wildenauer (2003) Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families.Am. J. Hum. Genet. 72, 185–190.

    Article  PubMed  CAS  Google Scholar 

  • Schwarcz R, A Rassoulpour, HQ Wu, D Medoff, CA Tamminga and RC Roberts (2001) Increased cortical kynurenate content in schizophrenia.Biol. Psychiatry 50, 521–530.

    Article  PubMed  CAS  Google Scholar 

  • Schwarz MJ, M Riedel, R Gruber, M Ackenheil and N Müller (1999) Antibodies to heat-shock proteins in schizophrenic patients — implications for disease mechanism.Am. J. Psychiatry 156, 1103–1104.

    PubMed  CAS  Google Scholar 

  • Schwarz MJ, M Riedel, M Ackenheil and N Müller (2000) Deceased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients.Biol. Psychiatry 47, 29–33.

    Article  PubMed  CAS  Google Scholar 

  • Schwarz MJ, S Chiang, N Müller and M Ackenheil (2001) T-helper-1 and T-helper-2 responses in psychiatric disorders.Brain Behav. Immunol. 15, 340–370.

    Article  CAS  Google Scholar 

  • Schwarz MJ, H Krönig, M Riedel, S Dehning, A Douhet, I Spellmann, M Ackenheil, HJ Möller and N Müller (2005) IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia.Eur. Arch. Psychiatry Clin. Neurosci. 256(2), 72–76. E-pub Aug 17.

    Article  PubMed  Google Scholar 

  • Schwieler L, G Engberg and S Erhardt(2004) Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.Synapse 52, 114–122.

    Article  PubMed  CAS  Google Scholar 

  • Schwieler L, S Erhardt, C Erhardt and G Engberg (2005) Prostaglandin-mediated control of rat brain kynurenic acid synthesis — opposite actions by COX-1 and COX-2 isoforms.J. Neural Transm. 112, 863–872.

    Article  PubMed  CAS  Google Scholar 

  • Seder RA and WE Paul (1994) Acquisition of lymphokine-producing phenotype by CD4+ T cells.Annu. Rev. Immunol. 12, 635–673.

    Article  PubMed  CAS  Google Scholar 

  • Shayegan DM and SM Stahl (2004) Atypical antipsychotics: matching receptor profile to individual patient’s clinical profile.CNS Spectrum 10 (Suppl. 11) 6–14.

    Google Scholar 

  • Skok M, R Grailhe and JP Changeux (2005) Nicotinic receptors regulate B lymphocyte activation and immune response.Eur. J. Pharmacol. 517, 246–251.

    Article  PubMed  CAS  Google Scholar 

  • Speciale C and R Schwarcz (1993) On the production and disposition of quinolinic acid in rat brain and liver slices.J. Neurochem. 60, 212–218.

    Article  PubMed  CAS  Google Scholar 

  • Speciale C, HQ Wu, M Cini, M Marconi, M Varasi and R Schwarcz (1996) (R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats.Eur. J. Pharmacol. 315, 263–267.

    Article  PubMed  CAS  Google Scholar 

  • Sperner-Unterweger B, C Miller, B Holzner, B Widner, WW Fleischhacker and D Fuchs (1999) Measurement of neopterin, kynurenine and tryptophan in sera of schizophrenic patients, In:Psychiatry, Psychimmunology, and Viruses (Müller N, Ed.) (Springer:Wien, NY), pp 115–119.

    Google Scholar 

  • Stalder AK, A Pagenstecher, NC Yu, C Kincaid, CS Chiang, MV Hobbs, FE Bloom and IL Campbell (1997) Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia.J. Immunol. 159, 1344–1351.

    PubMed  CAS  Google Scholar 

  • Stefansson H, E Sigurdsson, V Steinthorsdottir, S Bjornsdottir, T Sigmundsson, S Ghosh, J Brynjolfsson, S Gunnarsdottir, O Ivarsson, TT Chou, O Hjaltason, B Birgisdottir, H Jonsson, VG Gudnadottir, E Gudmundsdottir, A Bjornsson, B Ingvarsson, A Ingason, S Sigfusson, H Hardardottir, RP Harvey, D Lai, M Zhou, D Brunner, V Mutel, A Gonzalo, G Lemke, J Sainz, G Johannesson, T Andresson, D Gudbjartsson, A Manolescu, ML Frigge, ME Gurney, A Kong, JR Gulcher, H Petursson and K Stefansson (2002) Neuregulin 1 and susceptibility to schizophrenia.Am. J. Hum. Genet. 71, 877–892.

    Article  PubMed  Google Scholar 

  • Stefansson H, J Sarginson, A Kong, P Yates, V Steinthorsdottir, E Gudfinnsson, S Gunnarsdottir, N Walker, H Petursson, C Crombie, A Ingason, JR Gulcher, K Stefansson and D St Clair (2003) Association of neuregulin 1 with schizophrenia confirmed in a Scottish population.Am. J. Hum. Genet. 72, 83–87.

    Article  PubMed  CAS  Google Scholar 

  • Stolina M, S Sharma, Y Linet al. (2000) Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis.J. Immunol. 164, 361–370.

    PubMed  CAS  Google Scholar 

  • Stone TW (1993) Neuropharmacology of quinolinic and kynurenine acids.Pharmacol. Rev. 43, 309–379.

    Google Scholar 

  • Straub RE, Y Jiang, CJ MacLean, Y Ma, BT Webb, MV Myakishev, C Harris-Kerr, B Wormley, H Sadek, B Kadambi, AJ Cesare, A Gibberman, X Wang, FA O’Neill, D Walsh and KS Kendler (2002) Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.Am. J. Hum. Genet. 71, 337–348.

    Article  PubMed  CAS  Google Scholar 

  • Sullivan PF, KS Kendler and MC Neale (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.Arch. Gen. Psychiatry 60, 1187–1192.

    Article  PubMed  Google Scholar 

  • Sumiyoshi T, AE Anil, D Jin, K Jayathilake, M Lee and HY Meltzer (2004) Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms.Int. J. Neuropsychopharmacol. 7, 1–8.

    Article  PubMed  CAS  Google Scholar 

  • Sumiyoshi T, D Jin, K Jayathilake, M Lee and HJ Meltzer (2005) Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia.Int. J. Neuropsychopharmacol. 8, 1–5.

    Article  CAS  Google Scholar 

  • Suvisaari J, J Haukka, A Transkanen, T Hovi and J Lonnquist (1999) Association between prenatal exposure to poliovirus infection and adult schizophrenia.Am. J. Psychiatry 156, 1100–1102.

    PubMed  CAS  Google Scholar 

  • Takai N, PB Mortensen, U Klaening, RM Murray, PC Sham, E O’Callaghan and P Munk-Jorgensen (1996) Relationship betweenin utero exposure to influenza epidemics and risk of schizophrenia in Denmark.Biol. Psychiatry 40, 817–824.

    Article  Google Scholar 

  • Takikawa O, R Yoshida, R Kido and O Hayaishi (1986) Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.J. Biol. Chem. 261, 347–351.

    Google Scholar 

  • Talbot K, WL Eidem, CL Tinsley, MA Benson, EW Thompson, RJ Smith, CG Hahn, SJ Siegel, JQ Trojanowski, RE Gur, DJ Blake and SE Arnold (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.J. Clin. Invest. 113(9), 1353–1363.

    PubMed  CAS  Google Scholar 

  • Tanaka KF, F Shintani, Y Fujii, G Yagi and M Asai (2000) Serum interleukin-18 levels are elevated in schizophrenia.Psychiatry Res. 96, 75–80.

    Article  PubMed  CAS  Google Scholar 

  • Tharumaratnam D, S Bashford and SA Khan (2000) Indomethacin induced psychosis.Postgrad. Med. J. 76, 736–737.

    Article  PubMed  CAS  Google Scholar 

  • Tohmi M, N Tsuda, Y Watanabe, A Kakita and H Nawa (2004) Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin.Neurosci. Res. 50, 67–75.

    Article  PubMed  CAS  Google Scholar 

  • Torrey EF, J Miller, R Rawlings and RH Yolken (1997) Seasonality of births in schizophrenia and bipolar disorder: a review of the literature.Schizophr. Res. 28, 1–38.

    Article  PubMed  CAS  Google Scholar 

  • Tracey KJ (2002) The inflammatory reflex.Nature 420, 853–859.

    Article  PubMed  CAS  Google Scholar 

  • Tsai G, P Yang, LC Chung, N Lange and JT Coyle (1998) D-serine added to antipsychotics for the treatment of schizophrenia.Biol. Psychiatry 44, 1081–1089.

    Article  PubMed  CAS  Google Scholar 

  • Van Kammen DP, CG McAllister-Sistilli and ME Kelley (1997) Relationship between immune and behavioral measures in schizophrenia, In:Current Update in Psychoimmunology (Wieselmann G, Ed.) (Springer Verlag:Wien, NY), pp 51–55.

    Google Scholar 

  • Van Westerloo DJ, IAJ Giebelen, S Florquin, J Daalhuisen, MJ Bruno, AF de Vos, KJ Tracey and T van der Poll (2005)J. Infect. Dis. 191, 2138–2148.

    Article  PubMed  Google Scholar 

  • Villemain F, L Chatenoud, A Galinowski, F Homo Delarche, D Genestet, H Loo, E Zarifarain and JF Bach (1989) Aberrant T-cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production.Am. J. Psychiatry 146, 609–616.

    PubMed  CAS  Google Scholar 

  • Vinogradov S, II Gottesman, HW Moises and S Nicol (1991) Negative association between schizophrenia and rheumatoid arthritis.Schizophr. Bull. 17, 669–678.

    PubMed  CAS  Google Scholar 

  • Wang H, M Yu, M Ochani, CA Amelia, M Tanovic, S Susaria, JH Li, H Wang, H Yang, L Ulloa, Y Al-Abed, CJ Czura and KJ Tracey (2003) Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation.Nature 421, 384–388.

    Article  PubMed  CAS  Google Scholar 

  • Weickert TW and TE Goldberg (2000) The course of cognitive impairment in patients with schizophrenia, In:Cognition in Schizophrenia: Impairments, Importance and Treatment Strategies (Sharma T and P Harvey, Eds) (University Press: Oxford, NY), pp 3–15.

    Google Scholar 

  • Westergaard T, PB Mortensen, CB Pedersen, J Wohlfahrt and M Melbye (1999) Exposure to prenatal and childhood infections and the risk of schizophrenia: suggestions from a study of sibship characteristics and influenca prevalence.Arch. Gen. Psychiatry 56, 993–998.

    Article  PubMed  CAS  Google Scholar 

  • Wilke I, V Arolt, M Rothermundt, CH Weitzsch, M Hornberg and H Kirchner (1996) Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients.Eur. Arch. Psychiatry Clin. Neurosci. 246, 279–284.

    Article  PubMed  CAS  Google Scholar 

  • Williams NM, A Preece, G Spurlock, N Norton, HJ Williams, S Zammit, MC O’Donovan and M JOwen (2003) Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia.Mol. Psychiatry 8, 485–487.

    Article  PubMed  CAS  Google Scholar 

  • Wu HO, SC Lee, HE Scharfman and R Schwarcz (2002) L-4-chlo-rokynurenine attenuates kainate-induced seizures and lesions in the rat.Exp. Neurol. 177, 222–232.

    Article  PubMed  CAS  Google Scholar 

  • Xiao BG and H Link (1999) Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies?Immunology Today 20, 477–479.

    Article  PubMed  CAS  Google Scholar 

  • Yolken RH and EF Torrey (1995) Viruses, schizophrenia, and bipolar disorder.Clin. Microbiol. Rev. 8, 131–145.

    PubMed  CAS  Google Scholar 

  • Zimmer DB, EH Cornwall, A Landar and W Song (1995) The S100 protein family: history, function, and expression.Brain Res. Bull. 37, 417–429.

    Article  PubMed  CAS  Google Scholar 

  • Zuckerman L and I Weiner (2005) Maternal immune activation leads to behavioural and pharmacological changes in the adult offspring.J. Psychiatr. Res. 39, 311–323.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital for Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität, 80336, München, Germany

    Norbert MÜller & Markus Schwarz

Authors
  1. Norbert MÜller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Markus Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norbert MÜller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

MÜller, N., Schwarz, M. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. neurotox res 10, 131–148 (2006). https://doi.org/10.1007/BF03033242

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033242

Keywords

Search

Navigation